Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE

INTRODUCTION: Randomised controlled trials (RCTs) may use surrogate endpoints as substitutes and predictors of patient-relevant/participant-relevant final outcomes (eg, survival, health-related quality of life). Translation of effects measured on a surrogate endpoint into health benefits for patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Manyara, Anthony Muchai, Davies, Philippa, Stewart, Derek, Weir, Christopher J, Young, Amber, Butcher, Nancy J, Bujkiewicz, Sylwia, Chan, An-Wen, Collins, Gary S, Dawoud, Dalia, Offringa, Martin, Ouwens, Mario, Ross, Joseph S, Taylor, Rod S, Ciani, Oriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557267/
https://www.ncbi.nlm.nih.gov/pubmed/36220321
http://dx.doi.org/10.1136/bmjopen-2022-064304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557267/
https://www.ncbi.nlm.nih.gov/pubmed/36220321
http://dx.doi.org/10.1136/bmjopen-2022-064304

Ejemplares similares